{"schema_version":"secwatch.filing_event.v1","accession":"0001104659-25-025547","form_type":"8-K","ticker":"MIST","cik":"0001408443","company_name":"Milestone Pharmaceuticals Inc.","filed_at":"2025-03-19T23:59:59+00:00","discovered_at":"2026-05-14T18:03:03.543444+00:00","generated_at":"2026-05-24T11:37:46.495147+00:00","sec_items":["5.08"],"event_type":"other","sentiment":"neutral","materiality_score":0.2,"calibrated_materiality_score":0.2,"confidence":"high","headline":"Milestone Pharmaceuticals sets June 10, 2025 as annual meeting date; record date April 15","bullets":["2025 annual meeting scheduled for June 10, 2025; record date for voting is April 15, 2025.","Shareholder proposals under Rule 14a-8 must be received by the company secretary by March 29, 2025.","Proposals under Quebec Business Corporations Act and company by-laws due by April 15, 2025.","Universal proxy rule notice for director nominations must be provided by April 11, 2025."],"urls":{"canonical":"https://secwatch.observer/filing/0001104659-25-025547","json":"https://secwatch.observer/filing/0001104659-25-025547.json","markdown":"https://secwatch.observer/filing/0001104659-25-025547.md","text":"https://secwatch.observer/filing/0001104659-25-025547.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1408443/000110465925025547/0001104659-25-025547-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1408443/000110465925025547/tm259776d1_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-24T11:37:46.495147+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}